Press Releases

 

Company News

  Date Title and Summary View
Nov 30, 2005
Columbia, MD – November 30, 2005: CELSION CORPORATION (AMEX: CLN) today announced that two studies involving the investigation of ThermoDox in animals will be presented at the 2005 Annual Radiological Society of North America meeting in Chicago (November 27 to December 2, 2005). In the first study to be presented by Victor Fre...
Nov 9, 2005
Columbia, MD – November 9, 2005: CELSION CORPORATION (AMEX: CLN) today announced financial results for its third quarter ended September 30, 2005. The Company reported revenue of $3.2 million for the quarter, compared to $0.5 million for the third quarter of 2004. The Company recorded a net loss for the third quarter of $2.0 m...
Nov 8, 2005
Columbia, MD – November 8, 2005: CELSION CORPORATION (AMEX: CLN) today announced that it had agreed to provide Duke University with a research grant and clinical supplies of ThermoDox, Celsion's proprietary doxorubicin-encapsulated thermo-sensitive liposome, to support a Phase I, open-label study of the safety and pharmacokinetics in pa...
Nov 3, 2005
Columbia, MD – November 3, 2005- Celsion Corporation (AMEX: CLN) today announced that Dr. Lawrence Olanoff, Chief Executive Officer, was interviewed by Wall Street Reporter earlier today. In the interview, Dr. Olanoff elaborated on Celsion's transformation from a medical device company to biopharmaceutical company, solely focuse...
Nov 3, 2005
Wednesday, November 9, 2005 Columbia, MD – November 2, 2005: CELSION CORPORATION (AMEX: CLN) today announced that it would hold its regular quarterly shareholders' conference call at 11:00 a.m. Eastern Time on Wednesday, November 9, 2005. To participate in the call, interested parties can dial 800-366-7449 (domestic) or 303-26...
Aug 9, 2005
COLUMBIA, Md.--(BUSINESS WIRE)--Aug. 9, 2005--CELSION CORPORATION (AMEX:CLN) today announced that it had reached an agreement pursuant to which Boston Scientific Corporation (NYSE:BSX) will lend Celsion up to $15 million. The loan, which has a term expiring on February 20, 2009, will be disbursed in up to three installments and will bear inter...
Aug 8, 2005
COLUMBIA, Md.--(BUSINESS WIRE)--Aug. 8, 2005--CELSION CORPORATION (AMEX:CLN) today announced financial results for its second quarter ended June 30, 2005. The Company reported revenue of $2.9 million for the quarter, compared to $0.4 million for the second quarter of 2004. Revenue increased 53% over first quarter 2005 revenue of $1.9. ...
Aug 4, 2005
COLUMBIA, Md.--(BUSINESS WIRE)--Aug. 4, 2005--CELSION CORPORATION (AMEX:CLN) today announced that it would hold its regular quarterly shareholders' conference call at 11:00 a.m. Eastern Time on Tuesday, August 9, 2005. To participate in the call, interested parties can dial 800.510.9661 (domestic) or 617.614.3452 (international), access code: ...
Jul 29, 2005
COLUMBIA, Md.--(BUSINESS WIRE)--July 29, 2005--Celsion Corporation (AMEX:CLN) today reported the grant of a stock option award to Dr. Lawrence Olanoff, who commenced employment with Celsion as its President and Chief Executive Officer today. On May 18, 2005, the Board of Directors of Celsion approved the option grant to Dr. Olanoff effective a...
Jun 23, 2005
COLUMBIA, Md.--(BUSINESS WIRE)--June 23, 2005--CELSION CORPORATION (AMEX:CLN) today announced that, upon the recommendation of its Nominating Committee, effective June 20, 2005, its Board of Directors has acted to increase from five to six the number of directors constituting the whole Board of Directors and to fill the resulting vacancy by el...
Page: FirstPrevious ...
44
NextLast
= add release to Briefcase
Share This